Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÖzsu, Elif
dc.contributor.authorYeşiltepe Mutlu, Gül
dc.contributor.authorÇizmecioğlu, Filiz Mine
dc.contributor.authorBircan, Rifat
dc.contributor.authorHatun, Şükrü
dc.date.accessioned2022-05-11T14:28:22Z
dc.date.available2022-05-11T14:28:22Z
dc.date.issued2017
dc.identifier.issn2147-0634
dc.identifier.issn2147-0634
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TWpZek56a3lNZz09
dc.identifier.urihttps://hdl.handle.net/20.500.11776/6802
dc.description.abstractSubclinical hyperthyroidism is defined as low or undetectable concentration of serum thyrotrophin (TSH) with normal free triiodothyronine (FT3) and free thyroxine (FT4) levels. 1). Familial subclinical hyperthyroidism is a rare entity. Activating mutations of the TSH receptor (TSH-R) gene cause genetic hyperthyroidism. Here we present a family with more than one affected individual. All family members were investigated for TSH-R mutation. No mutation was detected, while a A459 polymorphism was found in one of the cases and three other siblings. Despite the clinical and biochemical findings suggesting a TSH-R mutation, a reasonable cause could not be detected. Epigenetic and environmental modifiers, including iodine intake, should be considered in families with mutation negative, familial non auto-immune hyperthyroidism (FNAH)en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGenel ve Dahili Tıpen_US
dc.titleTwo siblings with familial subclinical hyperthyroidism with unknown etiologyen_US
dc.typearticleen_US
dc.relation.ispartofMedicine Scienceen_US
dc.departmentFakülteler, Fen Edebiyat Fakültesi, Biyoloji Bölümüen_US
dc.identifier.volume6en_US
dc.identifier.issue1en_US
dc.identifier.startpage154en_US
dc.identifier.endpage156en_US
dc.institutionauthorBircan, Rifat
dc.identifier.trdizinidTWpZek56a3lNZz09en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster